Faculty

Institution

Unit

Venue

Qiwei Wang

Assistant Professor of Microbiology Immunology and Cancer Biology

University of Virginia

Affiliations

School of Medicine

Department of Microbiology, Immunology, and Cancer Biology

Qiwei Wang is currently serving as a Microbiology, Immunology, And Cancer Biology Assistant Professor of Microbiology Immunology and Cancer Biology at University of Virginia.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Qiwei Wang

University of Virginia

Assistant Professor of Microbiology Immunology and Cancer Biology

You can click a keyword to filter the displayed items

immunology cell biology vascular biology inflammation cell death cell signaling immune responses blood vessels therapeutic targets molecular cancer cardiovascular research oncogenes apoptosis cancer immunotherapy endothelial dysfunction pathology immunotherapy medicinal research molecular physiology cancer cells physiology vascular pharmacology abdominal aortic aneurysm cellular physiology cellular therapy cancer biology cancer treatment signal transduction chronic inflammation cancer immunosurveillance signaling pathways vascular disease general virology medical virology virus research gynecologic oncology tumor targeting anti-cancer agents nucleic acids small rna disease pathophysiology viral pathogenesis virus-host interactions immune checkpoint inhibitors inflammatory diseases tumor suppressors therapy resistance immunoediting parp inhibition controlled release microrna detection adaptive immune system infectious respiratory disease anti-inflammatory innate immune system cell regulation therapeutic efficacy digital gene expression prrsv infection aneurysm growth host immune system pharmaceutical nanotechnology nano-drug delivery polymer-drug conjugate therapeutic nanomaterials non-coding rna olaparib triggers red blood cell biomimetic nanotherapies overcomes resistance adipogenesis mechanism wnt signaling deep investigation mouse models vascular inflammation smc necrosis

Notable Scholarly Works

Notable Federal Grants

Collaborators

Acat1 Regulates Tertiary Lymphoid Structures: A Target for Enhancing Immunotherapy in Non–Small Cell Lung Cancer. Journal of Clinical Investigation (2025)

Sophie O'KeefeQiwei Wang

lung cancercancer immunotherapyhost responsetumor suppressorscancer immunosurveillancetherapeutic targetsclinical investigationcellular therapyoncologyimmunotherapysystems biologyimmunoeditinglymphoid neoplasiaimmunologytertiary lymphoid structurescancer cellsoncogenesthoracic oncologymolecular biology

Lysine Vitcylation is a Vitamin C-Derived Protein Modification That Enhances Stat1-Mediated Immune Response. Cell (2025)

Xiadi HeQiwei WangXin ChengWeihua WangYutong LiYabing NanJiang WuBingqiu XiuTao JiangJohann S BergholzHao GuFuhui ChenGuangjian FanLianhui SunShaozhen XieJunjie ZouSheng LinYun WeiJames LeeJohn M AsaraKe ZhangLewis C CantleyJean J Zhao

therapeutic targetspeptide sciencephytotherapy researchmolecular immunologylysine vitcylationinnate immune systempeptidesimmune responsesimmune dysregulationtherapy resistanceadaptive immune systemimmunologyimmunity (medicine)antioxidantsgene therapymedicinal researchbiomolecular engineeringinflammationmolecular biology

Radiation-Guided Nanoparticles Enhance the Efficacy of Parp Inhibitors in Primary and Metastatic Brca1-Deficient Tumors via Immunotherapy. Journal of Controlled Release (2025)

Rami KhouryGiuseppe LongobardiTania BarnatanDana VenkertAmérica García AlvaradoAdi YonaMarina Green BuzhorShir ShaharQiwei WangRita C AcúrcioRita C GuedesHelena F FlorindoJean J ZhaoRonit Satchi-Fainaro

radiation-guided nanoparticlesparp inhibitorsimmunotherapycontrolled releasetherapeutic efficacy

CORRECTION: Inhibition of the Transcriptional Kinase Cdk7 Overcomes Therapeutic Resistance in Her2-Positive Breast Cancers. Oncogene (2024)

Bowen SunSeth MasonRobert C. WilsonStarr E. HazardYubao WangRong FangQiwei WangElizabeth S. YehMeixiang YangThomas M. RobertsJean J. ZhaoQi Wang

cancer biologybreast oncologypharmacologytherapeutic targetscellular therapyoncologycancer researchcancer treatmentgeneticstherapy resistancemolecular cancergene therapybreast cancertherapeutic resistancemedicinal researchoncogenesmolecular biologyenzyme inhibitioncancer genetics

Abstract 282: Upregulation of Receptor Interacting Protein Kinase-3 Augments Abdominal Aortic Aneurysms. Arteriosclerosis Thrombosis and Vascular Biology (2023)

Jack BontekoeTing ZhouKartik GuptaHuan YangAmelia StranzMitri K KhouryZulmari Silva-PedrazaQiwei WangBo Liu

receptorsangiologycardiologypharmacologyvascular biologyphysiologyneurologythrombosisatherosclerosis

Pi3Kβ Controls Immune Evasion in Pten-Deficient Breast Tumours. Nature (2023)

Johann S. BergholzQiwei WangQi WangMichelle RamseierSanjay PrakadanWeihua WangRong FangSheheryar KabrajiQian ZhouG. Kenneth GrayKayley Abell-HartShaozhen XieXiaocan GuoHao GuThanh VonTao JiangShuang TangGordon J. FreemanHye-Jung KimAlex K. ShalekThomas M. RobertsJean J. Zhao

receptorscancer immunotherapymedicinetumor suppressorscancer immunosurveillancenaturetumor biologycancer genomicspten-deficient breast tumoursgeneticsmolecular canceradaptive immune systemimmunologytumor targetingbreast cancermedicinal researchinflammationcancer cellsoncogenes

Sting Agonism Overcomes Stat3-Mediated Immunosuppression and Adaptive Resistance to Parp Inhibition in Ovarian Cancer. Journal for ImmunoTherapy of Cancer (2023)

Liya DingQiwei WangAntons MartincuksMichael J KearnsTao JiangZiying LinXin ChengChangli QianShaozhen XieHye-Jung KimInga-Maria LaunonenAnniina FärkkiläThomas M RobertsGordon J FreemanJoyce F LiuPanagiotis A KonstantinopoulosUrsula MatulonisHua YuJean J Zhao

cancer immunotherapyhost responsecell biologyleukemiacancer immunosurveillancepharmacologytherapeutic targetsimmunosuppressioncellular therapyoncologyimmunotherapyadaptive resistanceclinical immunologycancer treatmentovarian cancergynecologic oncologymedicinal researchenzyme inhibitionpathology

Targeting Tumor-Associated Macrophages With Sting Agonism Improves the Antitumor Efficacy of Osimertinib in a Mouse Model of Egfr-Mutant Lung Cancer. Frontiers in Immunology (2023)

Ziying LinQiwei WangTao JiangWeihua WangJean J. Zhao

lung cancercancer immunotherapytumor suppressorstumor-associated macrophagescellular therapyimmunotherapytumor microenvironmenttherapeutic efficacyanti-cancer agentsimmune responsesinfectious diseasesimmunologyimmunopathologymouse modelmedicinal researchallergyantitumor efficacycancer cellsoncogenesthoracic oncologymucosal immunologyegfr-mutant lung cancer

Upregulation of Receptor Interacting Protein Kinase-3 Augments Abdominal Aortic Aneurysms. JVS Vascular Science (2023)

Jack BontekoeTing ZhouKartik GuptaHuan YangAmelia StranzMitri K. KhouryZulmari Silva-PedrazaQiwei WangBo Liu

receptorsbiomedical engineeringvascular biologyvascular disease

Abstract Lb004: Upregulation of Stat3 Signaling in Tumor Cells Fosters a Tme-Dependent Secondary Resistance of Brca1-Deficient Hgsoc to Parp Inhibition. Cancer Research (2022)

Liya DingQiwei WangMichael KearnsTao JiangXin ChengChangli QianJean Zhao

cancer biologydrug resistancecell biologycell signalingleukemiapharmacologycellular therapyoncologycancer researchcancer carecancer treatmentimmunologytumor targetingcytokinestumor cellsmedicinal researchtme-dependent secondary resistanceenzyme inhibitionclinical researchcancer genetics

1
2
3
4
5
10 / page

Qiwei Wang

Assistant Professor of Microbiology Immunology and Cancer Biology

University of Virginia

Affiliations

School of Medicine

Department of Microbiology, Immunology, and Cancer Biology

Qiwei Wang is currently serving as a Microbiology, Immunology, And Cancer Biology Assistant Professor of Microbiology Immunology and Cancer Biology at University of Virginia.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Qiwei Wang

University of Virginia

Assistant Professor of Microbiology Immunology and Cancer Biology

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Acat1 Regulates Tertiary Lymphoid Structures: A Target for Enhancing Immunotherapy in Non–Small Cell Lung Cancer. Journal of Clinical Investigation (2025)

Sophie O'KeefeQiwei Wang

Lysine Vitcylation is a Vitamin C-Derived Protein Modification That Enhances Stat1-Mediated Immune Response. Cell (2025)

Radiation-Guided Nanoparticles Enhance the Efficacy of Parp Inhibitors in Primary and Metastatic Brca1-Deficient Tumors via Immunotherapy. Journal of Controlled Release (2025)

radiation-guided nanoparticlesparp inhibitorsimmunotherapycontrolled releasetherapeutic efficacy

CORRECTION: Inhibition of the Transcriptional Kinase Cdk7 Overcomes Therapeutic Resistance in Her2-Positive Breast Cancers. Oncogene (2024)

Bowen SunSeth MasonRobert C. WilsonStarr E. HazardYubao WangRong FangQiwei WangElizabeth S. YehMeixiang YangThomas M. RobertsJean J. ZhaoQi Wang

Abstract 282: Upregulation of Receptor Interacting Protein Kinase-3 Augments Abdominal Aortic Aneurysms. Arteriosclerosis Thrombosis and Vascular Biology (2023)

Jack BontekoeTing ZhouKartik GuptaHuan YangAmelia StranzMitri K KhouryZulmari Silva-PedrazaQiwei WangBo Liu

receptorsangiologycardiologypharmacologyvascular biologyphysiologyneurologythrombosisatherosclerosis

Pi3Kβ Controls Immune Evasion in Pten-Deficient Breast Tumours. Nature (2023)

Sting Agonism Overcomes Stat3-Mediated Immunosuppression and Adaptive Resistance to Parp Inhibition in Ovarian Cancer. Journal for ImmunoTherapy of Cancer (2023)

Targeting Tumor-Associated Macrophages With Sting Agonism Improves the Antitumor Efficacy of Osimertinib in a Mouse Model of Egfr-Mutant Lung Cancer. Frontiers in Immunology (2023)

Ziying LinQiwei WangTao JiangWeihua WangJean J. Zhao

Upregulation of Receptor Interacting Protein Kinase-3 Augments Abdominal Aortic Aneurysms. JVS Vascular Science (2023)

Jack BontekoeTing ZhouKartik GuptaHuan YangAmelia StranzMitri K. KhouryZulmari Silva-PedrazaQiwei WangBo Liu

receptorsbiomedical engineeringvascular biologyvascular disease

Abstract Lb004: Upregulation of Stat3 Signaling in Tumor Cells Fosters a Tme-Dependent Secondary Resistance of Brca1-Deficient Hgsoc to Parp Inhibition. Cancer Research (2022)

Liya DingQiwei WangMichael KearnsTao JiangXin ChengChangli QianJean Zhao

1
2
3
4
5
10 / page

Similar Faculty Members

Jack A Elias

Institution

Brown University

respiratory medicine

cytokine

Serge Y. Fuchs

Institution

University of Pennsylvania

molecular biology

immunology

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Zihai Li

Institution

Medical University of South Carolina

immunology

immunotherapy

David Cheresh

Institution

University of California, San Diego

angiogenesis

matrix biology

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Robert A. Weinberg

Institution

Massachusetts Institute of Technology

cancer biology

cancer research

Arlene Sharpe

Institution

Harvard University

immunology

immune responses

Nigel Mackman

Institution

University of North Carolina at Chapel Hill

hemostasis

liver injury

Similar Faculty Members

Jack A Elias

Institution

Brown University

respiratory medicine

cytokine

Serge Y. Fuchs

Institution

University of Pennsylvania

molecular biology

immunology

Sanjay Srivastava

Institution

University of Louisville

volatile organic compounds

free radical biology

Zihai Li

Institution

Ohio State University

biomedical informatics

systems biology

Zihai Li

Institution

Medical University of South Carolina

immunology

immunotherapy

David Cheresh

Institution

University of California, San Diego

angiogenesis

matrix biology

Ralph R. Weichselbaum

Institution

University of Chicago

oncology

radiation oncology

Robert A. Weinberg

Institution

Massachusetts Institute of Technology

cancer biology

cancer research

Arlene Sharpe

Institution

Harvard University

immunology

immune responses

Nigel Mackman

Institution

University of North Carolina at Chapel Hill

hemostasis

liver injury